Trs20 is required for TRAPP III complex assembly at the PAS and its function in autophagy

Autor Taussig, David, Lipatova, Zhanna, Segev, Nava
Vydáno 2014

Trs20 is Required for TRAPP II Assembly

Autor Taussig, David, Lipatova, Zhanna, Kim, Jane, Zhang, XuiQi, Segev, Nava
Vydáno 2013

Antibody Repertoire Analysis of Tumor-Infiltrating B Cells Reveals Distinct Signatures and Distributions Across Tissues

Autor Aizik, Ligal, Dror, Yael, Taussig, David, Barzel, Adi, Carmi, Yaron, Wine, Yariv
Vydáno v Front Immunol (2021)

Regulation of selective autophagy onset by a Ypt/Rab GTPase module

Autor Lipatova, Zhanna, Belogortseva, Natalia, Zhang, Xiu Qi, Kim, Jane, Taussig, David, Segev, Nava
Vydáno 2012

Acute myeloid leukemia xenograft success prediction: Saving time

Autor Griessinger, Emmanuel, Vargaftig, Jacques, Horswell, Stuart, Taussig, David C., Gribben, John, Bonnet, Dominique
Vydáno v Exp Hematol (2018)

Butyrate Inhibits Cancerous HCT116 Colon Cell Proliferation but to a Lesser Extent in Noncancerous NCM460 Colon Cells

Autor Zeng, Huawei, Taussig, David P., Cheng, Wen-Hsing, Johnson, LuAnn K., Hakkak, Reza
Vydáno v Nutrients (2017)

TRAPPII Complex Assembly Requires Trs33 or Trs65

Autor Tokarev, Andrei A., Taussig, David, Sundaram, Geetanjali, Lipatova, Zhanna, Liang, Yongheng, Mulholland, Jonathan W., Segev, Nava
Vydáno 2009

A Niche-Like Culture System Allowing the Maintenance of Primary Human Acute Myeloid Leukemia-Initiating Cells: A New Tool to Decipher Their Chemoresistance and Self-Renewal Mechani...

Autor Griessinger, Emmanuel, Anjos-Afonso, Fernando, Pizzitola, Irene, Rouault-Pierre, Kevin, Vargaftig, Jacques, Taussig, David, Gribben, John, Lassailly, François, Bonnet, Dominique
Vydáno 2014

Frequency of Leukemic Initiating Cells does not depend on the xenotransplantation model used

Autor Vargaftig, Jacques, Taussig, David C., Griessinger, Emmanuel, Anjos-Afonso, Fernando, Lister, T.Andrew, Cavenagh, Jamie, Oakervee, Heather, Gribben, John, Bonnet, Dominique
Vydáno 2011

Single cell analysis of clonal architecture in acute myeloid leukaemia

Autor Potter, Nicola, Miraki-Moud, Farideh, Ermini, Luca, Titley, Ian, Vijayaraghavan, Gowri, Papaemmanuil, Elli, Campbell, Peter, Gribben, John, Taussig, David, Greaves, Mel
Vydáno v Leukemia (2018)

Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts

Autor Le Dieu, Rifca, Taussig, David C., Ramsay, Alan G., Mitter, Richard, Miraki-Moud, Faridah, Fatah, Rewas, Lee, Abigail M., Lister, T. Andrew, Gribben, John G.
Vydáno 2009

Characteristics of human primary mantle cell lymphoma engraftment in NSG mice

Autor Iyengar, Sunil, Ariza‐McNaughton, Linda, Clear, Andrew, Taussig, David, Auer, Rebecca, Roe, Amy, Lillington, Debra, Iqbal, Sameena, Joel, Simon, Gribben, John, Bonnet, Dominique
Vydáno v Br J Haematol (2015)

Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia

Autor Taussig, David C., Pearce, Daniel J., Simpson, Catherine, Rohatiner, Ama Z., Lister, T. Andrew, Kelly, Gavin, Luongo, Jennifer L., Danet-Desnoyers, Gwenn-aël H., Bonnet, Dominique
Vydáno 2005

AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML

Autor Pearce, Daniel J., Taussig, David, Zibara, Kazem, Smith, Lan-Lan, Ridler, Christopher M., Preudhomme, Claude, Young, Bryan D., Rohatiner, Ama Z., Lister, T. Andrew, Bonnet, Dominique
Vydáno 2006

Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia

Autor Waclawiczek, Alexander, Hamilton, Ashley, Rouault-Pierre, Kevin, Abarrategi, Ander, Albornoz, Manuel Garcia, Miraki-Moud, Farideh, Bah, Nourdine, Gribben, John, Fitzgibbon, Jude, Taussig, David, Bonnet, Dominique
Vydáno v J Clin Invest (2020)

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(−) fraction

Autor Taussig, David C., Vargaftig, Jacques, Miraki-Moud, Farideh, Griessinger, Emmanuel, Sharrock, Kirsty, Luke, Tina, Lillington, Debra, Oakervee, Heather, Cavenagh, Jamie, Agrawal, Samir G., Lister, T. Andrew, Gribben, John G., Bonnet, Dominique
Vydáno 2010

Repression of sphingosine kinase (SK)-interacting protein (SKIP) in acute myeloid leukemia diminishes SK activity and its re-expression restores SK function

Autor Ghazaly, Essam A., Miraki-Moud, Farideh, Smith, Paul, Gnanaranjan, Chathunissa, Koniali, Lola, Oke, Adedayo, Saied, Marwa H., Petty, Robert, Matthews, Janet, Stronge, Randal, Joel, Simon P., Young, Bryan D., Gribben, John, Taussig, David C.
Vydáno v J Biol Chem (2020)

Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation

Autor Miraki-Moud, Farideh, Anjos-Afonso, Fernando, Hodby, Katharine A., Griessinger, Emmanuel, Rosignoli, Guglielmo, Lillington, Debra, Jia, Li, Davies, Jeff K., Cavenagh, Jamie, Smith, Matthew, Oakervee, Heather, Agrawal, Samir, Gribben, John G., Bonnet, Dominique, Taussig, David C.
Vydáno 2013

Differential and tumor-specific expression of CD160 in B-cell malignancies

Autor Farren, Timothy W., Giustiniani, Jerome, Liu, Feng-Ting, Tsitsikas, Dimitris A., Macey, Marion G., Cavenagh, James D., Oakervee, Heather E., Taussig, David, Newland, Adrian C., Calaminici, Maria, Bensussan, Armand, Jenner, Michael, Gribben, John G., Agrawal, Samir G.
Vydáno v Blood (2011)

Improving CRISPR–Cas specificity with chemical modifications in single-guide RNAs

Autor Ryan, Daniel E, Taussig, David, Steinfeld, Israel, Phadnis, Smruti M, Lunstad, Benjamin D, Singh, Madhurima, Vuong, Xuan, Okochi, Kenji D, McCaffrey, Ryan, Olesiak, Magdalena, Roy, Subhadeep, Yung, Chong Wing, Curry, Bo, Sampson, Jeffrey R, Bruhn, Laurakay, Dellinger, Douglas J
Vydáno v Nucleic Acids Res (2018)